BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guarino MPL, Cocca S, Altomare A, Emerenziani S, Cicala M. Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed. World J Gastroenterol 2013; 19(31): 5029-5034 [PMID: 23964136 DOI: 10.3748/wjg.v19.i31.5029]
URL: https://www.wjgnet.com/1007-9327/full/v19/i31/5029.htm
Number Citing Articles
1
Ceyda Tuna Kirsaclioglu, Bahar Çuhacı Çakır, Gulsah Bayram, Fatih Akbıyık, Pamir Işık, Bahattin Tunç. Risk factors, complications and outcome of cholelithiasis in children: A retrospective, single-centre reviewJournal of Paediatrics and Child Health 2016; 52(10): 944 doi: 10.1111/jpc.13235
2
L. B. Lazebnik, E. V. Golovanova, S. V. Turkina, K. L. Raikhelson, S. V. Okovityy, O. M. Drapkina, I. V. Maev, A. I. Martynov, G. E. Roitberg, O. V. Khlynova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, A. O. Bueverov, E. V. Vinitskaya, G. V. Volynets, E. Yu. Eremina, V. B. Grinevich, A. I. Dolgushina, A. N. Kazyulin, E. I. Kashkina, I. V. Kozlova, Yu. V. Konev, N. V. Korochanskaya, Yu. A. Kravchuk, E. D. Li, I. D. Loranskaya, V. M. Makhov, S. N. Mekhtiev, V. P. Novikova, O. D. Ostroumova, Ch. S. Pavlov, V. G. Radchenko, A. A. Samsonov, A. S. Sarsenbaeva, R. G. Sayfutdinov, P. V. Seliverstov, S. I. Sitkin, O. V. Stefanyuk, L. V. Tarasova, E. I. Tkachenko, Yu. P. Uspensky, Yu. A. Fominykh, A. I. Khavkin, Yu. V. Tsyganova, O. O. Sharhun. Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third versionExperimental and Clinical Gastroenterology 2021; 1(1): 4 doi: 10.31146/1682-8658-ecg-185-1-4-52
3
Jennifer W. Uyeda, Ian J. Richardson, Aaron D. Sodickson. Making the invisible visible: improving conspicuity of noncalcified gallstones using dual-energy CTAbdominal Radiology 2017; 42(12): 2933 doi: 10.1007/s00261-017-1229-x
4
Ibrahim Guillermo Castro-Torres, Minarda De la O-Arciniega, Gustavo Adolfo Bravo-Duarte, Janeth Gallegos-Estudillo, Miguel Ángel Domínguez-Ortíz, Mariano Martínez-Vázquez. Intestinal and hepatic Niemann–Pick C1L1 proteins: Future therapeutic targets for cholesterol gallstones disease?European Journal of Pharmacology 2014; 728: 77 doi: 10.1016/j.ejphar.2014.01.067
5
James S. Dooley, Kurinchi S. Gurusamy, Brian R. Davidson. Sherlock's Diseases of the Liver and Biliary System2018; : 256 doi: 10.1002/9781119237662.ch14
6
Nasser Sakran, Ron Dar, Ahmad Assalia, Ziv Neeman, Moaad Farraj, Shiri Sherf-Dagan, Ian M. Gralnek, Rawi Hazzan, Shams Eldin Mokary, Hadar Nevo-Aboody, Tamar Dola, Uri Kaplan, Dan Hershko. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trialUpdates in Surgery 2020; 72(4): 1125 doi: 10.1007/s13304-020-00850-2
7
Gal Dubnov-Raz, Thomas H. Inge, Michal Ben-Ami, Reut Pienik, Irena Vusiker, Dani Yardeni. Body composition changes in adolescents after laparoscopic sleeve gastrectomySurgery for Obesity and Related Diseases 2016; 12(2): 322 doi: 10.1016/j.soard.2015.07.012
8
Andrew J. Lickteig, Iván L. Csanaky, Matthew Pratt-Hyatt, Curtis D. Klaassen. Activation of Constitutive Androstane Receptor (CAR) in Mice Results in Maintained Biliary Excretion of Bile Acids Despite a Marked Decrease of Bile Acids in LiverToxicological Sciences 2016; 151(2): 403 doi: 10.1093/toxsci/kfw054
9
Khaled A. Alhumaidha, Sally A. El-Awdan, Wafaa I. El-Iraky, Ezz-El-Din S. El-Denshary. Protective effects of ursodeoxycholic acid on ceftriaxone-induced hepatic injury in ratsBulletin of Faculty of Pharmacy, Cairo University 2014; 52(1): 45 doi: 10.1016/j.bfopcu.2014.02.002
10
E. I. Khoroshavina, M. V. Dubinin, V. N. Samartsev. Ursodeoxycholic acid, in contrast to other bile acids, induces Ca2+-dependent cyclosporin A-insensitive permeability transition in liver mitochondria in the presence of potassium chlorideBiochemistry (Moscow) Supplement Series A: Membrane and Cell Biology 2016; 10(4): 287 doi: 10.1134/S1990747816030144
11
A. V. Nersesov, D. A. Kaibullaeva, O. S. Vasnev, L. K. Tashenova, M. M. Sakhipov, G. T. Berestimov, G. A. Akhmetzhanova, O. T. Ibekenov, M. O. Doskhanov, N. M. Zhumazhanov, Zh. M. Balzhanov, B. A. Aitmoldin, E. A. Toleubaev, E. M. Laryushina, K. N. Zhumagulov, G. N. Sobirova, S. I. Umarova, Yu. O. Shulpekova, A. V. Okhlobystin. A modern conception of postcholecystectomy syndrome (based on the materials of the Advisory Board held on May 4, 2019 in Almaty, Kazakhstan)FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology 2020; 13(2): 205 doi: 10.17749/2070-4909/farmakoekonomika.2020.036
12
Dong Ki Lee, Sung Ill Jang. Diseases of the Gallbladder2020; : 85 doi: 10.1007/978-981-15-6010-1_8
13
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventionsLife Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
14
Elena Ratti, James D. Berry, David J. Greenblatt, Lorena Loci, Amy Swartz Ellrodt, Jeremy M. Shefner, Merit E. Cudkowicz. Preclinical rodent toxicity studies for long term use of ceftriaxoneToxicology Reports 2015; 2: 1396 doi: 10.1016/j.toxrep.2015.09.010
15
Yeoun Joo Lee, Yeh Seul Park, Jae Hong Park. Cholecystectomy is Feasible in Children with Small-Sized or Large Numbers of Gallstones and in Those with Persistent Symptoms Despite Medical TreatmentPediatric Gastroenterology, Hepatology & Nutrition 2020; 23(5): 430 doi: 10.5223/pghn.2020.23.5.430
16
T.D. Zvyagintseva, I.I. Shargorod. Phatological state after cholecystectomy: from pathogenesis to treatmentShidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2017; 2017(2): 9 doi: 10.15407/internalmed2017.02.009
17
Ekaterina Dikman, Yuliya Zyuzkova, Irina Nam, Andrey Kolomeytsev, Anatoly Chirev. Progress in Material Science and EngineeringStudies in Systems, Decision and Control 2021; 351: 237 doi: 10.1007/978-3-030-68103-6_21
18
Christoph G.W. Gertzen, Holger Gohlke, Dieter Häussinger, Diran Herebian, Verena Keitel, Ralf Kubitz, Ertan Mayatepek, Lutz Schmitt. The many facets of bile acids in the physiology and pathophysiology of the human liverBiological Chemistry 2021; 0(0) doi: 10.1515/hsz-2021-0156
19
Kyo-Sang Yoo. Management of GallstoneThe Korean Journal of Gastroenterology 2018; 71(5): 253 doi: 10.4166/kjg.2018.71.5.253
20
J. JUŘICA, G. DOVRTĚLOVÁ, K. NOSKOVÁ, O. ZENDULKA. Bile Acids, Nuclear Receptors and Cytochrome P450Physiological Research 2016; : S427 doi: 10.33549/physiolres.933512
21
Ekaterina Dikman, Alexey Soldatov, Anatoly Chirev. The study of the possibility of drug dissolution of gallbladder calculiSensor Review 2020; 40(3): 363 doi: 10.1108/SR-12-2019-0301
22
S. Ramukutty, R. Jeyasudha, E. Ramachandran. Thermal Decomposition Kinetics of Ursodeoxycholic Acid Drug CrystalJournal of Crystallization Process and Technology 2017; 7(04): 85 doi: 10.4236/jcpt.2017.74006
23
Ibrahim Guillermo Castro-Torres, René de Jesús Cárdenas-Vázquez, Claudia Velázquez-González, Rosa Ventura-Martínez, Minarda De la O-Arciniega, Elia Brosla Naranjo-Rodríguez, Mariano Martínez-Vázquez. Future therapeutic targets for the treatment and prevention of cholesterol gallstonesEuropean Journal of Pharmacology 2015; 765: 366 doi: 10.1016/j.ejphar.2015.08.045
24
GamalM Saied, KarimG Moustafa. Mechanical parameters and chemical composition of gallstones in Egyptian population: an approach to assess amenability to nonsurgical treatmentThe Egyptian Journal of Surgery 2020; 39(1): 271 doi: 10.4103/ejs.ejs_202_19
25
Amber Littlefield, Christy Lenahan. Cholelithiasis: Presentation and ManagementJournal of Midwifery & Women's Health 2019; 64(3): 289 doi: 10.1111/jmwh.12959
26
Shu-Chao Weng, Hung-Chang Lee, Chun-Yan Yeung, Wai-Tao Chan, Hsi-Che Liu, Chuen-Bin Jiang. Choledochal cyst as an important risk factor for pediatric gallstones in low-incidence populations: A single-center reviewPediatrics & Neonatology 2020; 61(6): 598 doi: 10.1016/j.pedneo.2020.07.013
27
Songül BUDAK DİLER, Fikriye POLAT, Eyüp ÖZER. Ursodeoksikolik Asit’in İnsan Periferal Kan Lenfositlerindeki in Vitro Genotoksik EtkisiJournal of the Institute of Science and Technology 2018; 8(1): 69 doi: 10.21597/jist.407835
28
N. Prencipe, C. Bona, D. Cuboni, M. Parasiliti-Caprino, A. M. Berton, L. M. Fenoglio, V. Gasco, E. Ghigo, S. Grottoli. Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatmentPituitary 2021; 24(2): 242 doi: 10.1007/s11102-020-01102-7
29
Ju Kyoung Oh, You Ra Kim, Boin Lee, Young Min Choi, Sae Hun Kim. Prevention of Cholesterol Gallstone Formation by Lactobacillus acidophilus ATCC 43121 and Lactobacillus fermentum MF27 in Lithogenic Diet-Induced MiceFood Science of Animal Resources 2021; 41(2): 343 doi: 10.5851/kosfa.2020.e93
30
P. V. Seliverstov, T. E. Skvortsova, S. I. Sitkin, V. G. Radchenko. Treatment Options for Patients with Gallstones (Cholelithiasis)Medical Council 2019; (14): 44 doi: 10.21518/2079-701X-2019-14-44-51
31
Ibrahim Guillermo Castro-Torres, Víctor Alberto Castro-Torres, Minerva Hernández-Lozano, Marcos Fernando Ocaña-Sánchez. Food Bioactives and Health2021; : 159 doi: 10.1007/978-3-030-57469-7_5